[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR3065009B1 - Secretome bacterien pour son utilisation dans le traitement des lesions cutanees - Google Patents

Secretome bacterien pour son utilisation dans le traitement des lesions cutanees Download PDF

Info

Publication number
FR3065009B1
FR3065009B1 FR1753012A FR1753012A FR3065009B1 FR 3065009 B1 FR3065009 B1 FR 3065009B1 FR 1753012 A FR1753012 A FR 1753012A FR 1753012 A FR1753012 A FR 1753012A FR 3065009 B1 FR3065009 B1 FR 3065009B1
Authority
FR
France
Prior art keywords
treatment
skin lesions
bacterial secretome
secretome
bacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1753012A
Other languages
English (en)
Other versions
FR3065009A1 (fr
Inventor
Rizzi Nathalie Castex
Marie Florence Galliano
Pigeon Helene Hernandez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Dermo Cosmetique SA
Original Assignee
Pierre Fabre Dermo Cosmetique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1753012A priority Critical patent/FR3065009B1/fr
Application filed by Pierre Fabre Dermo Cosmetique SA filed Critical Pierre Fabre Dermo Cosmetique SA
Priority to EP18716267.2A priority patent/EP3607049A1/fr
Priority to MX2019011951A priority patent/MX2019011951A/es
Priority to AU2018248899A priority patent/AU2018248899B2/en
Priority to SG11201909144V priority patent/SG11201909144VA/en
Priority to CN201880029816.3A priority patent/CN111630152B/zh
Priority to JP2019554772A priority patent/JP7334119B2/ja
Priority to PCT/EP2018/058929 priority patent/WO2018185324A1/fr
Priority to RU2019134658A priority patent/RU2794128C2/ru
Priority to US16/603,002 priority patent/US11484555B2/en
Priority to CA3059380A priority patent/CA3059380A1/fr
Priority to KR1020197029200A priority patent/KR102585934B1/ko
Priority to BR112019020954A priority patent/BR112019020954A2/pt
Priority to TW107112150A priority patent/TW201841647A/zh
Publication of FR3065009A1 publication Critical patent/FR3065009A1/fr
Application granted granted Critical
Publication of FR3065009B1 publication Critical patent/FR3065009B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/36—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne une nouvelle utilisation d'un sécrétome bactérien dans le domaine du traitement des lésions cutanées et plus particulièrement de la cicatrisation. L'invention a également pour objet des compositions cosmétiques ou dermatologiques comprenant un tel sécrétome bactérien comme agent actif.
FR1753012A 2017-04-06 2017-04-06 Secretome bacterien pour son utilisation dans le traitement des lesions cutanees Active FR3065009B1 (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FR1753012A FR3065009B1 (fr) 2017-04-06 2017-04-06 Secretome bacterien pour son utilisation dans le traitement des lesions cutanees
CA3059380A CA3059380A1 (fr) 2017-04-06 2018-04-06 Secretome bacterien pour son utilisation dans le traitement des lesions cutanees
AU2018248899A AU2018248899B2 (en) 2017-04-06 2018-04-06 Bacterial secretome for use in the treatment of skin lesions
SG11201909144V SG11201909144VA (en) 2017-04-06 2018-04-06 Bacterial secretome for use in the treatment of skin lesions
CN201880029816.3A CN111630152B (zh) 2017-04-06 2018-04-06 用于治疗皮肤损伤的细菌分泌物组
JP2019554772A JP7334119B2 (ja) 2017-04-06 2018-04-06 皮膚損傷の処置に使用するための細菌セクレトーム
PCT/EP2018/058929 WO2018185324A1 (fr) 2017-04-06 2018-04-06 Sécrétome bactérien pour son utilisation dans le traitement des lésions cutanées
RU2019134658A RU2794128C2 (ru) 2017-04-06 2018-04-06 Бактериальный секретом для применения в лечении повреждений кожи
EP18716267.2A EP3607049A1 (fr) 2017-04-06 2018-04-06 Sécrétome bactérien pour son utilisation dans le traitement des lésions cutanées
MX2019011951A MX2019011951A (es) 2017-04-06 2018-04-06 Secretoma bacteriano para usarse en el tratamiento contra lesiones cutaneas.
KR1020197029200A KR102585934B1 (ko) 2017-04-06 2018-04-06 피부 병변의 치료에 사용되는 박테리아성 세크레톰
BR112019020954A BR112019020954A2 (pt) 2017-04-06 2018-04-06 secretoma bacteriano para uso no tratamento de lesões de pele
US16/603,002 US11484555B2 (en) 2017-04-06 2018-04-06 Bacterial secretome for use in the treatment of skin lesions
TW107112150A TW201841647A (zh) 2017-04-06 2018-04-09 用於治療皮膚損傷之細菌性分泌蛋白質體

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1753012A FR3065009B1 (fr) 2017-04-06 2017-04-06 Secretome bacterien pour son utilisation dans le traitement des lesions cutanees
FR1753012 2017-04-06

Publications (2)

Publication Number Publication Date
FR3065009A1 FR3065009A1 (fr) 2018-10-12
FR3065009B1 true FR3065009B1 (fr) 2020-11-27

Family

ID=59811390

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1753012A Active FR3065009B1 (fr) 2017-04-06 2017-04-06 Secretome bacterien pour son utilisation dans le traitement des lesions cutanees

Country Status (13)

Country Link
US (1) US11484555B2 (fr)
EP (1) EP3607049A1 (fr)
JP (1) JP7334119B2 (fr)
KR (1) KR102585934B1 (fr)
CN (1) CN111630152B (fr)
AU (1) AU2018248899B2 (fr)
BR (1) BR112019020954A2 (fr)
CA (1) CA3059380A1 (fr)
FR (1) FR3065009B1 (fr)
MX (1) MX2019011951A (fr)
SG (1) SG11201909144VA (fr)
TW (1) TW201841647A (fr)
WO (1) WO2018185324A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3081705B1 (fr) * 2018-06-01 2020-12-04 Fabre Pierre Dermo Cosmetique Extrait et composition dermatologique le comprenant pour le traitement des peaux sensibles
WO2022155881A1 (fr) * 2021-01-22 2022-07-28 佛山科学技术学院 Bactérie kbfs1720 de source cutanée ayant une fonction de réparation des brûlures dues aux ultraviolets sur la peau, et son application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4800015B2 (ja) * 2005-11-22 2011-10-26 株式会社カロッツェリアジャパン 皮膚炎発症抑制のための微生物培養物並びにそれらを用いた製品
FR2969657B1 (fr) * 2010-12-22 2014-02-07 Fabre Pierre Dermo Cosmetique Nouvelle bacterie et extraits de ladite bacterie et leur utilisation en dermatologie
FR2969658B1 (fr) * 2010-12-22 2014-10-17 Fabre Pierre Dermo Cosmetique Nouvelle bacterie et extraits de ladite bacterie et leur utilisation therapeutique
IL222127B (en) * 2012-09-24 2018-06-28 Dr Nona Int Ltd Topical halobactria extract composiiton for treating radiation skin tissue damage

Also Published As

Publication number Publication date
BR112019020954A2 (pt) 2020-05-05
AU2018248899B2 (en) 2024-09-26
KR102585934B1 (ko) 2023-10-06
FR3065009A1 (fr) 2018-10-12
MX2019011951A (es) 2019-11-07
US11484555B2 (en) 2022-11-01
CA3059380A1 (fr) 2018-10-11
US20200030387A1 (en) 2020-01-30
RU2019134658A (ru) 2021-05-06
CN111630152B (zh) 2023-07-04
WO2018185324A1 (fr) 2018-10-11
JP2020513007A (ja) 2020-04-30
KR20190138640A (ko) 2019-12-13
RU2019134658A3 (fr) 2021-07-28
EP3607049A1 (fr) 2020-02-12
JP7334119B2 (ja) 2023-08-28
AU2018248899A1 (en) 2019-11-28
SG11201909144VA (en) 2019-11-28
TW201841647A (zh) 2018-12-01
CN111630152A (zh) 2020-09-04

Similar Documents

Publication Publication Date Title
FR3028753B1 (fr) Gel aqueux ou hydroalcoolique de phyllosilicates synthetiques a titre d'agent viscosant, matifiant et/ou homogeneisant d'application
MA39094A1 (fr) Polythérapie comprenant un inhibiteur de mdm2 et un ou plusieurs principes pharmaceutiquement actifs supplémentaires pour le traitement de cancers
MA41411B1 (fr) Compositions dispersibles
MA41060B1 (fr) Compositions comprenant des souches bactériennes
MA55434B1 (fr) Compositions comprenant des souches bactériennes
MA41010A (fr) Compositions comprenant des souches bactériennes
MA34650B1 (fr) Antagonistes du récepteur cgrp de pipéridinone carboxamide azaindane
FR3055799B1 (fr) Nouvelle utilisation cosmetique et/ou nutraceutique ou dermatologique d'un extrait de levure
MA34724B1 (fr) Nouvelle forme d'administration d'un inhibiteur de l'enképhalinase
MA39179A1 (fr) Complexes de cuivre-ammonium et complexes de cuivre-zinc-ammonium solubilisés en milieu acide, compositions, préparations, procédés et utilisations
MA50406B1 (fr) Inhibiteurs pyrazole de magl
MA44948A1 (fr) Inhibiteurs de bace 1
MA20150279A1 (fr) (r)-nifuratel, son utilisation pour le traitement d'infections et synthèse de (r) et (s)-nifuratel
MA38810B1 (fr) Inhibiteurs de rorc2 méthodes d'utilisation associées
FR3065009B1 (fr) Secretome bacterien pour son utilisation dans le traitement des lesions cutanees
FR2934782B1 (fr) Kit pour le traitement des onychomycoses.
MA36538B1 (fr) Utilisation de composition a base d'extraits de microalgues marines pour le traitement d'acne
FR3073142B1 (fr) Formulation cosmetique
FR3081705B1 (fr) Extrait et composition dermatologique le comprenant pour le traitement des peaux sensibles
FR3074421B1 (fr) Extrait d'helichrysum gymnocephalum pour le traitement et/ou la prevention des dermatoses inflammatoires
FR3044223B1 (fr) Composition cosmetique et utilisation
FR3064482B1 (fr) Composition topique de doxycycline
FR3095588B1 (fr) Nouvelle formulation topique modulant les voies de la nociception
FR3080764B1 (fr) Association d'extraits de quinquina et de leontopodium alpinum et du sel de manganese de l'acide carboxylique l-pyrrolidone dans le traitement de l'alopecie
FR3046353B1 (fr) Extrait de cassia alata contre la peau seche a tendance atopique

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20181012

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8